Definition of mild to moderate ulcerative colitis in clinical trials: A systematic literature review

被引：13

作者：

Caron, Benedicte ^{[1
,2
]}

Jairath, Vipul ^{[3
,4
,5
]}

D'Amico, Ferdinando ^{[6
,7
,8
]}

Paridaens, Kristine ^{[9
]}

Magro, Fernando ^{[10
,11
,12
]}

Danese, Silvio ^{[6
,7
]}

Peyrin-Biroulet, Laurent ^{[1
,2
]}

机构：

[1] Univ Lorraine, Nancy Univ Hosp, Dept Gastroenterol, 1 Allee Morvan, F-54511 Nancy, France

[2] Univ Lorraine, Nancy Univ Hosp, INSERM, NGERE U1256, 1 Allee Morvan, F-54511 Nancy, France

[3] Western Univ, Dept Med, London, ON, Canada

[4] Western Univ, Dept Epidemiol & Biostat, London, ON, Canada

[5] Alimentiv Inc, London, ON, Canada

[6] IRCCS Osped San Raffaele, Gastroenterol & Endoscopy, Milan, Italy

[7] Univ Vita Salute San Raffaele Milano, Milan, Italy

[8] Humanitas Univ, Dept Biomed Sci, Milan, Italy

[9] Ferring Int Ctr, St Prex, Switzerland

[10] Univ Porto, Fac Med, Unit Pharmacol & Therapeut, Dept Biomed, Porto, Portugal

[11] Sao Joao Univ Hosp Ctr CHUSJ, Dept Clin Pharmacol, Porto, Portugal

[12] Univ Porto, Fac Med, Ctr Hlth Technol & Serv Res CINTESIS, Porto, Portugal

来源：

UNITED EUROPEAN GASTROENTEROLOGY JOURNAL | 2022年 / 10卷 / 08期

关键词：

definition; mild; moderate; predictive factor; ulcerative colitis; RELEASE ORAL MESALAMINE; INFLAMMATORY-BOWEL-DISEASE; 400 MG TABLETS; DOUBLE-BLIND; BECLOMETHASONE DIPROPIONATE; MESALAZINE TABLETS; BUDESONIDE FOAM; MMX MESALAZINE; DOUBLE-DUMMY; EFFICACY;

D O I：

10.1002/ueg2.12283

中图分类号：

R57 [消化系及腹部疾病];

学科分类号：

摘要：

We performed a systematic review to investigate the definition of mild to moderate active ulcerative colitis (UC), and to describe predictors of good response to treatment in clinical trials assessing 5-ASA and/or budesonide. Thirty-nine randomized controlled trials were included. The UC Disease Activity Index (UCDAI) was the most frequent score used for defining mild to moderate active UC (16 studies, 41%), followed by Clinical Activity Index in 11 studies (28.2%). Four different cut-offs were used to define mild to moderate active UC using the UCDAI. The most frequently reported predictors of good response to treatment was a mild and moderate disease activity. There is heterogeneity in the definition of mild to moderate active UC in randomized clinical trials. A standardized definition of mild to moderate active UC used for inclusion of patients in clinical trials is needed.

引用

页码：854 / 867

页数：14

共 59 条

[51] Variations in the medical treatment of inflammatory bowel disease among gastroenterologists [J].